Consolidated Zinc consolidates Tres Amigos zone

|

Published 10-NOV-2015 15:45 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Consolidated Zinc (ASX:CZL) continues to prove up the Tres Amigos zone at its Plomosas zinc mine in Mexico, with recent drilling extending the known ore zone out over 300m of dip and 150m of strike.

The small cap zinc chaser told the market today that assays from several drill holes drilled to test the extent of the Tres Amigos zone, below the historically mined Main Manto Horizon, returned grades of up to 26.5% zinc.

While the drilling was designed to extend the known mineralisation, CZL has previously stated that it thinks this mineralised zone may extend 400m to the south-south east and 800m to the north west where the upper reaches of the zone were mined previously.

CZL said the zone still remains open, meaning further drilling will be needed to fully test the extent of the zone.

It will continue to drill the zone in the next four to six weeks, but it will continue to sample the main mineralised zone ‘Level 7’ in conjunction with the Tres Amigos drilling.

CZL said that should results at Tres Amigos track as they have done so far, then it would seek to fold this new zone into a scoping study to see whether a re-commissioned plant could be re-opened to provide short-term cash flow.

About Consolidated Zinc (ASX:CZL)

The main project for CZL is the Plomosas Zinc Project in Mexico.

It has been mined to the tune of 2 million tonnes of ore in the past, with an average zinc + lead grade of 22%. It has mined down to 270m below the surface.

CZL currently has a 51% stake in the project, but is aiming to increase this to above 80%.

It covers 11 exploration concessions covering over 3000 hectares in the northern Mexican state of Chihuahua, about two hours flight from Dallas to the north east.

CZL is aiming to initially focus on a 200tpd processing plant which is already present on site, using cashflow from early production to fund exploration.

It has focused on the project due to the high-grade nature of the zinc ore mined in the area to date.

tags

ZINC


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X